Sign in
4

Changes in Ownership

Arcadia Biosciences, Inc. Filed Acc 0001209191-23-026079

Options or other derivatives

  • Chief Financial Officer acquired 1,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Schaefer Thomas J. Chief Financial Officer 2023-04-04 Grant or award · Stock Option (Right to Buy) +1,500 5,475 D
Loading xslF345X04/doc4.xml…